*April 2021*
Lung cancer expert Dr. Pasi Janne, a professor of medicine at Harvard Medical School and a translational thoracic medical oncologist at the Dana-Farber Cancer Institute, speaks about EGFR treatments including post-progression following osimertinib. This is a very informative podcast and easy to understand. Listen to the podcast or read the transcript here.
